If we take the p53 over-expression as a predictive marker, the occurrence of positive samples in our population is probably too low to discriminate lesions at “high risk” of malignancy, also considering that not all p53-positive lesions will progress to cancer [37]. This evidence concerns the gene TP53 and cancer.